Evidence map›Paper›PMID 25887288›Full record

ArticleBMC infectious diseases2015

Colonisation with ESBL-producing and carbapenemase-producing Enterobacteriaceae, vancomycin-resistant enterococci, and meticillin-resistant Staphylococcus aureus in a long-term care facility over one year.

Catherine Ludden, Martin Cormican, Akke Vellinga, James R Johnson, Bernie Austin, Dearbháile Morris

Abstract read
In one paragraph

Article in BMC infectious diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Occurrence of Healthcare-Associated Infections (HAIs) byPathogens (Basel, Switzerland) · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Genomic surveillance ofMicrobial genomics · 2020
    Article
  17. Article
  18. Article
  19. Article
  20. Colonisation with pathogenic drug-resistant bacteria andAntimicrobial resistance and infection control · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Catherine LuddenDiscipline of Bacteriology, School of Medicine, National University of Ireland Galway, Galway, Ireland. cl636@medschl.cam.ac.uk.
Martin CormicanDiscipline of Bacteriology, School of Medicine, National University of Ireland Galway, Galway, Ireland. martin.cormican@hse.ie.
Akke VellingaDiscipline of Bacteriology, School of Medicine, National University of Ireland Galway, Galway, Ireland. akke.vellinga@nuigalway.ie.
James R JohnsonVA Medical Center, Minneapolis, MN, USA. johns007@umn.edu.
Bernie AustinSt. Brendan's Home, Community Nursing Unit, Galway, Ireland. bernie.austin@hse.ie.
Dearbháile MorrisDiscipline of Bacteriology, School of Medicine, National University of Ireland Galway, Galway, Ireland. dearbhaile.morris@nuigalway.ie.

Funding

Gut reservoir of E. coli ST131I01CX000920 · VA · MINNEAPOLIS VA MEDICAL CENTER · PI JOHNSON, JAMES R · 2014 to 2021
–
CSRD VA I01 CX000920
6 · The paper itself

Abstract

backgroundThis study examined colonisation with and characteristics of antimicrobial-resistant organisms among residents of a long-term care facility (LTCF) over one year, including strain persistence and molecular diversity among isolates of extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae.

methodsSixty-four residents of a LTCF were recruited (51 at baseline, 13 during the year). Data on dependency levels, hospitalisations, and antimicrobial prescribing were collected. Nasal and rectal swabs and catheter urine specimens were examined quarterly, using chromogenic agars, for ESBL-producing Enterobacteriaceae, carbapenemase-producing Enterobacteriaceae (CPE), vancomycin-resistant enterococci (VRE), and meticillin-resistant S. aureus (MRSA). All ESBL-producing E. coli (ESBL-EC) were characterised by pulsed-field gel electrophoresis (PFGE) and PCR to assess for sequence type (ST) ST131, its resistance-associated H30 and H30-Rx subclones, and blaCTX-M, blaTEM, blaSHV, and blaOXA-1.

resultsThe overall number of residents colonised, by organism, was as follows: ESBL-EC, 35 (55%); MRSA, 17 (27%); ESBL-producing K. pneumoniae (ESBL-KP), 5 (8%); VRE, 2 (3%) and CPE, 0 (0%). All 98 ESBL-EC isolates were H30-Rx ST131, with bla CTX-M-group 1. By PFGE, a group of 91 ESBL-EC (from 33 participants) had ≥85% similar profiles and resembled UK epidemic strain A/ international pulsotype PFGE812. Sequential ESBL-EC from individual residents were closely related. Six ESBL-KP isolates, from five participants, had bla CTX-M-group 1 and by PFGE were closely related. Colonisation with ESBL and MRSA was associated with location within the LTCF and previous exposure to antimicrobials.

conclusionsAmong LTCF residents, colonisation with ESBL-EC and MRSA was common. All ESBL-EC were H30-Rx ST131, consistent with clonal dissemination.

Indexed as

Nursing HomesAgedAged, 80 and overBacterial Proteinsbeta-LactamasesCarrier StateElectrophoresis, Gel, Pulsed-FieldEnterobacteriaceaeEnterobacteriaceae InfectionsEscherichia coliEscherichia coli InfectionsFemaleGram-Negative Bacterial InfectionsGram-Positive Bacterial InfectionsHumansKlebsiella InfectionsBacterial Proteinsbeta-Lactamasesbeta-lactamase TEM-3carbapenemaseMethicillin

Identifiers

PMID25887288
PMCPMC4399485

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.